| abstract |
The present invention relates to novel thiazolyldihydroindazoles of the general formula (I) where the R<1>, R<2> and R<3> radicals are each as defined in the claims and the description, to their tautomers, racemates, enantiomers, diastereomers and mixtures thereof, and where appropriate to their pharmacologically safe acid addition salts, solvates and hydrates, and to processes for preparing these thiazolyldihydroindazoles and to their use as medicaments. |